| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004167245 |
| P356 | DOI | 10.1186/1475-2891-6-42 |
| P932 | PMC publication ID | 2228298 |
| P698 | PubMed publication ID | 18053236 |
| P5875 | ResearchGate publication ID | 5795337 |
| P2093 | author name string | Lotfi Achour | |
| Alain Attar | |||
| Yoram Bouhnik | |||
| Damien Paineau | |||
| Francis Bornet | |||
| Michel Riottot | |||
| P2860 | cites work | Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans | Q24541358 |
| Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics | Q28303404 | ||
| Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits | Q33223485 | ||
| The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. | Q34374509 | ||
| Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. | Q34489016 | ||
| The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans | Q34567483 | ||
| Long‐term effect ofbifidobacteriaand Neosugar on precursor lesions of colonic cancer in cf1 mice | Q34582253 | ||
| Colorectal polyps in the elderly: what should be done? | Q34767477 | ||
| Probiotics and prebiotics in the elderly | Q35520051 | ||
| Intestinal bacteria and ageing | Q36797288 | ||
| Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects | Q37572553 | ||
| Role of bile acids and neutral sterols in carcinogenesis. | Q39520375 | ||
| Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut | Q39640631 | ||
| Biohydrogenation of sterols and fatty acids by the intestinal microflora | Q39951756 | ||
| Health benefits of non-digestible oligosaccharides | Q41637067 | ||
| Transit through the gut measured by analysis of a single stool | Q43248938 | ||
| The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides--a human volunteer study | Q43746853 | ||
| Effects of prebiotics on the immune response to vaccination in the elderly | Q44197637 | ||
| Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber) | Q44623491 | ||
| Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. | Q53445762 | ||
| Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. | Q53458112 | ||
| Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. | Q53597255 | ||
| Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. | Q54688097 | ||
| Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin | Q56627599 | ||
| Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans | Q68356512 | ||
| Effect of fructo-oligosaccharides on intestinal microflora | Q69406441 | ||
| Effects of some poorly digestible carbohydrates on bile acid bacterial transformations in the rat | Q69745220 | ||
| Bile acids and cancer of the large bowel | Q70186644 | ||
| Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat | Q70638647 | ||
| Digestion, excretion, and energy value of fructooligosaccharides in healthy humans | Q71465566 | ||
| Fate of fructo-oligosaccharides in the human intestine | Q71547576 | ||
| Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis | Q73248738 | ||
| Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats | Q74308884 | ||
| STUDIES WITH THE HYDROXYSTEROID DEHYDROGENASES. I. A SIMPLIFIED METHOD FOR THE ENZYMATIC ESTIMATION OF 3- AND 17-HYDROXYSTEROIDS | Q76856282 | ||
| P921 | main subject | oligosaccharide | Q320607 |
| feces | Q496 | ||
| P304 | page(s) | 42 | |
| P577 | publication date | 2007-12-05 | |
| P1433 | published in | Nutrition Journal | Q15751205 |
| P1476 | title | Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers | |
| P478 | volume | 6 |
| Q54263480 | A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. |
| Q42407992 | A Strong Impact of Genetic Background on Gut Microflora in Mice |
| Q64087165 | A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora |
| Q54349390 | A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. |
| Q35678151 | Aging of the human metaorganism: the microbial counterpart |
| Q33623914 | Antioxidant activity of inulin and its role in the prevention of human colonic muscle cell impairment induced by lipopolysaccharide mucosal exposure |
| Q37938810 | Benefits of dietary fiber in clinical nutrition |
| Q35412870 | Compositional dynamics of the human intestinal microbiota with aging: implications for health. |
| Q102152403 | Dietary fibre in gastrointestinal health and disease |
| Q37438244 | Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study |
| Q37384950 | Effect of a Growing-up Milk Containing Synbiotics on Immune Function and Growth in Children: A Cluster Randomized, Multicenter, Double-blind, Placebo Controlled Study |
| Q34255452 | Effect of prebiotics on the human gut microbiota of elderly persons |
| Q47229743 | Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice. |
| Q43324307 | Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients |
| Q43334475 | Effects of feeding potato pulp on cholesterol metabolism and its association with cecal conditions in rats |
| Q37359706 | Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study |
| Q61806307 | Effects of β-Fructans Fiber on Bowel Function: A Systematic Review and Meta-Analysis |
| Q57300415 | Efficacy of an Anthocyanin and Prebiotic Blend on Intestinal Environment in Obese Male and Female Subjects |
| Q33460457 | Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly |
| Q55332864 | Gut microbiome and aging: Physiological and mechanistic insights. |
| Q94672030 | Gut microbiota and Covid-19- possible link and implications |
| Q38211512 | Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects. |
| Q36198753 | Human gut microbiota: the links with dementia development |
| Q44527892 | Immunological properties of inulin-type fructans |
| Q38336066 | Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model |
| Q35113979 | Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly. |
| Q27003836 | Microbiota and healthy ageing: observational and nutritional intervention studies |
| Q57112973 | Mode of delivery and early nutrition modulate microbial colonization and fermentation products in neonatal piglets |
| Q52604165 | Modulations in the offspring gut microbiome are refractory to postnatal synbiotic supplementation among juvenile primates. |
| Q37972071 | Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. |
| Q50915635 | Practical approaches to the nutritional management of nonalcoholic fatty liver disease. |
| Q34141652 | Prebiotic effects: metabolic and health benefits |
| Q93109023 | Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation |
| Q45774281 | Probiotic supplement consumption alters cytokine production from peripheral blood mononuclear cells: a preliminary study using healthy individuals |
| Q37423648 | Probiotics for preventive health |
| Q57677254 | Selection of potential probiotic bifidobacteria and prebiotics for elderly by using in vitro faecal batch cultures |
| Q47157589 | Short-chain fructooligosaccharides from sucrose and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q34955829 | Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study |
| Q33782411 | Tolerability and safety of the intake of bovine milk oligosaccharides extracted from cheese whey in healthy human adults |
| Q35757434 | Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trial |
| Q30487021 | Understanding gut microbiota in elderly's health will enable intervention through probiotics |
Search more.